Celularity

(NASDAQ) CELU

Current Price$0.94

Market Cap$27.60M

Since IPO (2019)-99%

5 Year-99%

1 Year-39%

1 Month-27%

Celularity Financials at a Glance

Market Cap

$27.60M

Revenue (TTM)

$40.58M

Net Income (TTM)

$80.64M

EPS (TTM)

$-3.33

P/E Ratio

-0.29

Dividend

$0.00

Beta (Volatility)

1.34 (Average)

Dividend

$0.00

Beta (Volatility)

1.34 (Average)

Price

$0.94

Volume

31,617

Open

$0.97

Price

$0.94

Volume

31,617

Open

$0.97

Previous Close

$0.94

Daily Range

$0.94 - $0.97

52-Week Range

$0.93 - $4.35

Dividend

$0.00

Beta (Volatility)

1.34 (Average)

Price

$0.94

Volume

31,617

Open

$0.97

Previous Close

$0.94

Daily Range

$0.94 - $0.97

52-Week Range

$0.93 - $4.35

CELU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Celularity

Industry

Biotechnology

Sector

Health Care

Employees

123

CEO

Robert Joseph Hariri Gordon, MD, PhD

Website

www.celularity.com

Headquarters

Florham Park, NJ 07932, US

CELU Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

-6367%

Return on Capital

-2%

Return on Assets

-75%

Earnings Yield

-3.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$27.60M

Shares Outstanding

28.84M

Volume

31.62K

Avg. Volume

178.49K

Financials (TTM)

Gross Profit

$20.19M

Operating Income

$61.31M

EBITDA

$61.31M

Operating Cash Flow

$13.25M

Capital Expenditure

$0.00

Free Cash Flow

$13.25M

Cash & ST Invst.

$6.17M

Total Debt

$68.16M

Celularity Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$5.28M

-43.2%

Gross Profit

$3.27M

-39.7%

Gross Margin

61.81%

N/A

Market Cap

$27.60M

N/A

Market Cap/Employee

$229.98K

N/A

Employees

120

N/A

Net Income

$23.07M

-43.3%

EBITDA

$19.73M

-58.5%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$61.98M

+9.0%

Accounts Receivable

$4.65M

-65.7%

Inventory

$571.00K

-89.4%

Long Term Debt

$58.60M

-6.2%

Short Term Debt

$9.56M

+50.3%

Return on Assets

-75.14%

N/A

Return on Invested Capital

-1.83%

N/A

Free Cash Flow

$4.16M

-2223.5%

Operating Cash Flow

$4.16M

-2788.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.20-2.44%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

ANVSAnnovis Bio, Inc.

ANVSAnnovis Bio, Inc.$2.00+1.52%

PYPDPolyPid Ltd.

PYPDPolyPid Ltd.$4.44-1.33%

TPSTTempest Therapeutics, Inc.

TPSTTempest Therapeutics, Inc.$2.04+2.51%

BCABBioAtla, Inc.

BCABBioAtla, Inc.$4.27+1.43%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About CELU

What is the current price of Celularity?

Celularity is trading at $0.94 per share.

What is the 52-week range for Celularity?

Over the past 52 weeks, Celularity has traded between $0.93 and $4.35.

How much debt does Celularity have?

As of the most recent reporting period, Celularity reported total debt of $66.76M.

How much cash does Celularity have on hand?

Celularity reported $120,000 in cash and cash equivalents in its most recent financial results.

What is Celularity’s dividend yield?

Celularity does not currently have a dividend yield.

Celularity

Celularity Financials at a Glance

CELU News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Celularity

CELU Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Celularity Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CELU

What is the current price of Celularity?

What is the 52-week range for Celularity?

How much debt does Celularity have?

How much cash does Celularity have on hand?

What is Celularity’s dividend yield?

Premium Investing Services